Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Multicenter, Open-Label, Parallel Group Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Unfractionated Heparin as Anticoagulant Treatment in Patients Undergoing Haemodialysis Via an Arteriovenous Graft

NCT00074620 is registered in ClinicalTrials.gov with Speedel Pharma Ltd. as lead sponsor.

NCT NCT00074620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00074620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Multicenter, Open-Label, Parallel Group Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Unfractionated Heparin as Anticoagulant Treatment in Patients Undergoing Haemodialysis Via an Arteriovenous Graft
Lead sponsor
Speedel Pharma Ltd.
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2003
Completion date
January 31, 2006
Enrollment
260
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney failure, vascular graft occlusion